Cancer remains one of the most complex and costly health challenges facing employers today. For self-funded organizations, it has ranked as the number one cost driver for the past four years. High cancer costs are often driven by late-stage diagnoses and treatment pathways for cancers without established screenings. Fortunately, GRAIL’s Galleri® test is helping change that with a cutting-edge approach to early cancer screening.
Why is early detection important?
Early detection can significantly improve outcomes and help manage costs. However, approximately 70 percent of cancer deaths in the U.S. stem from cancer types without widely recommended or routine screening tests. In addition, many common cancers don’t show noticeable symptoms until later stages. At that point, treatment costs can be up to seven times higher and survival rates can drop dramatically—from 80–90 percent to just over 20 percent.
About Galleri from GRAIL
This is where the Galleri test from GRAIL is changing the game. Galleri, a multi-cancer early detection test, is a simple blood test designed to detect a cancer signal shared by more than 50 types of cancer. Unlike traditional screenings that focus on a single cancer, Galleri takes a broader, more comprehensive approach—helping to screen for cancers that might otherwise go undetected until symptoms appear. This includes many aggressive forms, such as pancreatic, liver, and ovarian cancers, among others.
Now available through Meritain Health®, Galleri offers employers an innovative way to support earlier detection and more informed care pathways.
A new way to support employee well-being
Galleri can be a game changer for employers looking to move beyond the status quo in cancer detection. It represents a meaningful step for cost-conscious organizations that want to prioritize employee well-being. By empowering eligible members with access to advanced, smart technology, employers can take a more proactive role in addressing one of today’s most pressing health challenges.
Contact your Meritain Health representative to learn more.
